A phase 1 study of AMG 900, an orally administered pan‐aurora kinase inhibitor, in adult patients with acute myeloid leukemia

JOURNAL ARTICLE published July 2017 in American Journal of Hematology

Authors: Hagop M. Kantarjian | Michael W. Schuster | Nitin Jain | Anjali Advani | Elias Jabbour | Erick Gamelin | Erik Rasmussen | Gloria Juan | Abraham Anderson | Vincent F. Chow | Gregory Friberg | Florian D. Vogl | Mikkael A. Sekeres